110 related articles for article (PubMed ID: 4728765)
1. Serum diphenylhydantoin, triglyceride and cholesterol concentration.
Reimer DR; Nagaswami S
N Engl J Med; 1973 Oct; 289(15):808-9. PubMed ID: 4728765
[No Abstract] [Full Text] [Related]
2. Serum level of phenobarbital or/and diphenylhydantoin in epileptics with some preexisting serum lipid alterations. Correlations with the treatment efficiency in epilepsy.
Rogozea R; Florea-Ciocoiu V; Balaita C; Luca N
Acta Neurol Belg; 1981; 81(1):24-32. PubMed ID: 7223355
[TBL] [Abstract][Full Text] [Related]
3. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy.
Nikolaos T; Stylianos G; Chryssoula N; Irini P; Christos M; Dimitrios T; Konstantinos P; Antonis T
Med Sci Monit; 2004 Apr; 10(4):MT50-2. PubMed ID: 15039653
[TBL] [Abstract][Full Text] [Related]
4. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M
Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151
[TBL] [Abstract][Full Text] [Related]
5. [Determination of serum diphenylhydantoin during antiepileptic therapy].
Müller-Stüler M
Nervenarzt; 1976 Apr; 47(4):244-7. PubMed ID: 1272481
[No Abstract] [Full Text] [Related]
6. Interrelation at plasmatic level between antiepileptic drugs and lipids. Its implications in the efficiency of treatment in epilepsy. II. Influence of some lipid changes upon treatment with phenobarbital or/and diphenylhydantoin.
Rogozea R; Florea-Ciocoiu V; Bălăiţă C; Luca N
Neurol Psychiatr (Bucur); 1981; 19(1):3-11. PubMed ID: 7221416
[No Abstract] [Full Text] [Related]
7. Diphenylhydantoin dosage.
Eadie MJ; Tyrer JH; Hooper WD
Proc Aust Assoc Neurol; 1973; 10(0):53-9. PubMed ID: 4792162
[No Abstract] [Full Text] [Related]
8. Changes in serum triglyceride and cholesterol levels during long-term phenytoin treatment for epilepsy.
Luoma PV; Reunanen MI; Sotaniemi EA
Acta Med Scand; 1979; 206(3):229-31. PubMed ID: 495231
[TBL] [Abstract][Full Text] [Related]
9. [Serum cholesterol and triglyceride levels in a Munich population group: relations to age and sex (author's transl)].
Henze K; Wallmüller-Strycker A; Bauer M; Barth C; Wolfram G; Zöllner N
J Clin Chem Clin Biochem; 1981 Oct; 19(10):1013-9. PubMed ID: 6975799
[TBL] [Abstract][Full Text] [Related]
10. Effect of phenytoin and valproic acid therapy on serum lipid levels and liver function tests.
Dewan P; Aggarwal A; Faridi MM
Indian Pediatr; 2008 Oct; 45(10):855-8. PubMed ID: 18948659
[TBL] [Abstract][Full Text] [Related]
11. [Influence of anti-epileptic drugs on blood lipid parameters: preliminary data].
Morgante L; Serra S; Musolino R; Gallitto G
Boll Soc Ital Biol Sper; 1981 Feb; 57(3):297-303. PubMed ID: 7236405
[TBL] [Abstract][Full Text] [Related]
12. [Anti epileptic therapy with diphenylhydantoin with serum controls in childhood. Clinical experiences].
Nolte R; Brügmann G; Besch W
Bibl Psychiatr; 1975; (151):43-8. PubMed ID: 1156347
[No Abstract] [Full Text] [Related]
13. [Diphenylhydantoin poisoning due to diphenylhydantoin-isoniazid interaction].
Geering JM; Ruch W; Dettli L
Schweiz Med Wochenschr; 1974 Aug; 104(35):1224-8. PubMed ID: 4445849
[No Abstract] [Full Text] [Related]
14. [Plasma diphenylhydantoin concentration in epileptic patients].
Herishanu Y; Eylath U
Harefuah; 1974 Sep; 87(6):251-3. PubMed ID: 4442797
[No Abstract] [Full Text] [Related]
15. [A case of association of migraine, epilepsy and hyperlipemia type V].
Serratrice G; Billé J; Roux H; Oliver C; Gastaut JL; Vovan L
Rev Neurol (Paris); 1971 Oct; 125(4):302-5. PubMed ID: 5153342
[No Abstract] [Full Text] [Related]
16. [Diphenylhydantoin in the comprehensive treatment of epileptic attacks].
Kolínová M; Kristof M; Maresová S
Cesk Neurol Neurochir; 1982 Nov; 45(6):410-7. PubMed ID: 7151206
[No Abstract] [Full Text] [Related]
17. [Ethnic differences in serum phenytoin levels].
Dam M; Hübbe P; Christiansen J
Ugeskr Laeger; 1974 Aug; 136(35):1974-6. PubMed ID: 4848674
[No Abstract] [Full Text] [Related]
18. [The diffusion of diphenylhydantoin across the cellophane membrane of the artificial kidney in a patient with uremia and epilepsy].
Desjacques P
Schweiz Rundsch Med Prax; 1972 Mar; 61(13):418-23. PubMed ID: 5020101
[No Abstract] [Full Text] [Related]
19. [Control of diphenylhydantoin dosage in epileptic seizures by determination of the serum levels].
Hirschmann J
Med Welt; 1969 Mar; 13():705-10. PubMed ID: 5784349
[No Abstract] [Full Text] [Related]
20. [Determination of optimal diphenylhydantoin dosage by monitoring serum concentrations].
Weintraub M; Halkin H; Shaked Y; Almog S
Harefuah; 1980 Oct; 99(8):213-5. PubMed ID: 7215973
[No Abstract] [Full Text] [Related]
[Next] [New Search]
